drugset / Trial / NCT01104870

A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension

NCT01104870

Phase 2 Completed 50 enrolled United Therapeutics
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, randomized, parallel group study to assess the hemodynamic effect of three different dose regimens of a sustained release (SR) tablet of UT-15C in patients with exercise-induced pulmonary hypertension (PH), as measured by the change in peak total pulmonary resistance index (TPRI) during exercise from Baseline to Week 12.

Timeline

Start
2010-04
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Treprostinil diethanolamine Unknown 0.25 mg Oral
Comparator Treprostinil diethanolamine Unknown 1.25 mg Oral